Metabolic adaptation of tissues to stress releases metabolites influencing innate immunity

Current Opinion in Immunology

Volumn 38, Issue , 2016, Pages 30-38

  Naquet, Philippe ^a   Giessner, Caroline ^a   Galland, Franck ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; ADENOSINE TRIPHOSPHATE; INFLAMMASOME; MERCAPTAMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; SUCCINIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

CELL PROTECTION; CELL SURVIVAL; CHRONIC INFLAMMATION; CITRIC ACID CYCLE; CYTOKINE PRODUCTION; FATTY ACID OXIDATION; HUMAN; HYPOXIA; INFLAMMATORY DISEASE; INNATE IMMUNITY; MACROPHAGE ACTIVATION; METABOLITE; NONHUMAN; NUTRITIONAL DEFICIENCY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PENTOSE PHOSPHATE CYCLE; RESPIRATORY CHAIN; REVIEW; SECOND MESSENGER; STRESS; TISSUE METABOLISM; TISSUE REGENERATION; ADAPTATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; METABOLOME; PHYSIOLOGICAL STRESS; PLANT;

ADAPTATION, PHYSIOLOGICAL; ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CITRIC ACID CYCLE; CYTOPROTECTION; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; METABOLOME; OXIDATIVE PHOSPHORYLATION; PLANTS; PPAR ALPHA; SECOND MESSENGER SYSTEMS; STRESS, PHYSIOLOGICAL;

EID: 84947561715     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.10.005     Document Type: Review

References (119)

1. Shulzhenko N., Morgun A., Hsiao W., Battle M., Yao M., Gavrilova O., Orandle M., Mayer L., Macpherson A.J., McCoy K.D., et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 2011, 17:1585-1593.
2. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
3. Green D.R., Galluzzi L., Kroemer G. Cell biology. Metabolic control of cell death. Science 2014, 345:1250256.
4. Bristow R.G., Hill R.P. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008, 8:180-192.
5. Biddlestone J., Bandarra D., Rocha S. The role of hypoxia in inflammatory disease (review). Int J Mol Med 2015, 35:859-869.
6. Tsalikis J., Croitoru D.O., Philpott D.J., Girardin S.E. Nutrient sensing and metabolic stress pathways in innate immunity. Cell Microbiol 2013, 15:1632-1641.
7. Ghesquiere B., Wong B.W., Kuchnio A., Carmeliet P. Metabolism of stromal and immune cells in health and disease. Nature 2014, 511:167-176.
8. Buck M.D., O'Sullivan D., Pearce E.L. T cell metabolism drives immunity. J Exp Med 2015, 212:1345-1360.
9. Nizet V., Johnson R.S. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009, 9:609-617.
10. Lunt S.Y., Vander Heiden M.G. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol 2011, 27:441-464.
11. Hardie D.G., Ross F.A., Hawley S.A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012, 13:251-262.
12. Papandreou I., Cairns R.A., Fontana L., Lim A.L., Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006, 3:187-197.
13. Kim J.W., Tchernyshyov I., Semenza G.L., Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006, 3:177-185.
14. Guzy R.D., Hoyos B., Robin E., Chen H., Liu L., Mansfield K.D., Simon M.C., Hammerling U., Schumacker P.T. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 2005, 1:401-408.
15. Brunelle J.K., Bell E.L., Quesada N.M., Vercauteren K., Tiranti V., Zeviani M., Scarpulla R.C., Chandel N.S. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab 2005, 1:409-414.
16. Salminen A., Kauppinen A., Kaarniranta K. 2-Oxoglutarate-dependent dioxygenases are sensors of energy metabolism, oxygen availability, and iron homeostasis: potential role in the regulation of aging process. Cell Mol Life Sci 2015, 72:3897-3914.
17. Chen S., Yin C., Lao T., Liang D., He D., Wang C., Sang N. AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1alpha and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol. Cell Cycle 2015, 14:2520-2536.
18. Chouchani E.T., Pell V.R., Gaude E., Aksentijevic D., Sundier S.Y., Robb E.L., Logan A., Nadtochiy S.M., Ord E.N., Smith A.C., et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 2014, 515:431-435.
19. Eoh H., Rhee K.Y. Multifunctional essentiality of succinate metabolism in adaptation to hypoxia in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 2013, 110:6554-6559.
20. Pecsi I., Hards K., Ekanayaka N., Berney M., Hartman T., Jacobs W.R., Cook G.M. Essentiality of succinate dehydrogenase in Mycobacterium smegmatis and its role in the generation of the membrane potential under hypoxia. MBio 2014, 5.
21. Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y., Zwaans B.M., Skinner M.E., et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol Cell 2013, 50:919-930.
22. Rardin M.J., He W., Nishida Y., Newman J.C., Carrico C., Danielson S.R., Guo A., Gut P., Sahu A.K., Li B., et al. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab 2013, 18:920-933.
23. Gutierrez-Aguilar M., Baines C.P. Physiological and pathological roles of mitochondrial SLC25 carriers. Biochem J 2013, 454:371-386.
24. Weinberg J.M., Venkatachalam M.A., Roeser N.F., Nissim I. Mitochondrial dysfunction during hypoxia/reoxygenation and its correction by anaerobic metabolism of citric acid cycle intermediates. Proc Natl Acad Sci U S A 2000, 97:2826-2831.
25. Chen T.T., Maevsky E.I., Uchitel M.L. Maintenance of homeostasis in the aging hypothalamus: the central and peripheral roles of succinate. Front Endocrinol (Lausanne) 2015, 6:7.
26. Mills E., O'Neill L.A. Succinate: a metabolic signal in inflammation. Trends Cell Biol 2014, 24:313-320.
27. De Minicis S., Seki E., Uchinami H., Kluwe J., Zhang Y., Brenner D.A., Schwabe R.F. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007, 132:1937-1946.
28. Rubic T., Lametschwandtner G., Jost S., Hinteregger S., Kund J., Carballido-Perrig N., Schwarzler C., Junt T., Voshol H., Meingassner J.G., et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat Immunol 2008, 9:1261-1269.
29. Vegran F., Boidot R., Michiels C., Sonveaux P., Feron O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis. Cancer Res 2011, 71:2550-2560.
30. Chan D.A., Kawahara T.L., Sutphin P.D., Chang H.Y., Chi J.T., Giaccia A.J. Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment. Cancer Cell 2009, 15:527-538.
31. Colegio O.R., Chu N.Q., Szabo A.L., Chu T., Rhebergen A.M., Jairam V., Cyrus N., Brokowski C.E., Eisenbarth S.C., Phillips G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 2014, 513:559-563.
32. Jha A.K., Huang S.C., Sergushichev A., Lampropoulou V., Ivanova Y., Loginicheva E., Chmielewski K., Stewart K.M., Ashall J., Everts B., et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 2015, 42:419-430.
33. Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., Frezza C., Bernard N.J., Kelly B., Foley N.H., et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature 2013, 496:238-242.
34. West A.P., Brodsky I.E., Rahner C., Woo D.K., Erdjument-Bromage H., Tempst P., Walsh M.C., Choi Y., Shadel G.S., Ghosh S. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480.
35. Nagy C., Haschemi A. Time and demand are two critical dimensions of immunometabolism: the process of macrophage activation and the pentose phosphate pathway. Front Immunol 2015, 6:164.
36. Wise D.R., Ward P.S., Shay J.E., Cross J.R., Gruber J.J., Sachdeva U.M., Platt J.M., DeMatteo R.G., Simon M.C., Thompson C.B. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A 2011, 108:19611-19616.
37. Infantino V., Iacobazzi V., Menga A., Avantaggiati M.L., Palmieri F. A key role of the mitochondrial citrate carrier (SLC25A1) in TNFalpha- and IFNgamma-trggered inflammation. Biochim Biophys Acta 2014, 1839:1217-1225.
38. Palmieri E.M., Spera I., Menga A., Infantino V., Porcelli V., Iacobazzi V., Pierri C.L., Hooper D.C., Palmieri F., Castegna A. Acetylation of human mitochondrial citrate carrier modulates mitochondrial citrate/malate exchange activity to sustain NADPH production during macrophage activation. Biochim Biophys Acta 2015, 1847:729-738.
39. Palazon A., Goldrath A.W., Nizet V., Johnson R.S. HIF transcription factors, inflammation, and immunity. Immunity 2014, 41:518-528.
40. Marino G., Pietrocola F., Eisenberg T., Kong Y., Malik S.A., Andryushkova A., Schroeder S., Pendl T., Harger A., Niso-Santano M., et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol Cell 2014, 53:710-725.
41. Tschopp J. Mitochondria: sovereign of inflammation?. Eur J Immunol 2011, 41:1196-1200.
42. Canto C., Menzies K.J., Auwerx J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab 2015, 22:31-53.
43. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., Mayo M.W. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.
44. Alano C.C., Garnier P., Ying W., Higashi Y., Kauppinen T.M., Swanson R.A. NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death. J Neurosci 2010, 30:2967-2978.
45. Haag F., Adriouch S., Brass A., Jung C., Moller S., Scheuplein F., Bannas P., Seman M., Koch-Nolte F. Extracellular NAD and ATP partners in immune cell modulation. Purinergic Signal 2007, 3:71-81.
46. Aksoy P., White T.A., Thompson M., Chini E.N. Regulation of intracellular levels of NAD: a novel role for CD38. Biochem Biophys Res Commun 2006, 345:1386-1392.
47. Partida-Sanchez S., Goodrich S., Kusser K., Oppenheimer N., Randall T.D., Lund F.E. Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity. Immunity 2004, 20:279-291.
48. Adriouch S., Hubert S., Pechberty S., Koch-Nolte F., Haag F., Seman M. NAD+ released during inflammation participates in T cell homeostasis by inducing ART2-mediated death of naive T cells in vivo. J Immunol 2007, 179:186-194.
49. Hubert S., Rissiek B., Klages K., Huehn J., Sparwasser T., Haag F., Koch-Nolte F., Boyer O., Seman M., Adriouch S. Extracellular NAD+ shapes the Foxp3+ regulatory T cell compartment through the ART2-P2X7 pathway. J Exp Med 2010, 207:2561-2568.
50. Rissiek B., Haag F., Boyer O., Koch-Nolte F., Adriouch S. ADP-ribosylation of P2X7: a matter of life and death for regulatory T cells and natural killer T cells. Curr Top Microbiol Immunol 2015, 384:107-126.
51. Idzko M., Ferrari D., Eltzschig H.K. Nucleotide signalling during inflammation. Nature 2014, 509:310-317.
52. Choi J., Tanaka K., Cao Y., Qi Y., Qiu J., Liang Y., Lee S.Y., Stacey G. Identification of a plant receptor for extracellular ATP. Science 2014, 343:290-294.
53. Csoka B., Nemeth Z.H., Toro G., Idzko M., Zech A., Koscso B., Spolarics Z., Antonioli L., Cseri K., Erdelyi K., et al. Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing. FASEB J 2015, 29:3626-3637.
54. Adamson S.E., Leitinger N. The role of pannexin1 in the induction and resolution of inflammation. FEBS Lett 2014, 588:1416-1422.
55. Romero S., Grompone G., Carayol N., Mounier J., Guadagnini S., Prevost M.C., Sansonetti P.J., Van Nhieu G.T. ATP-mediated Erk1/2 activation stimulates bacterial capture by filopodia, which precedes Shigella invasion of epithelial cells. Cell Host Microbe 2011, 9:508-519.
56. Yao Y., Levings M.K., Steiner T.S. ATP conditions intestinal epithelial cells to an inflammatory state that promotes components of DC maturation. Eur J Immunol 2012, 42:3310-3321.
57. Idzko M., Hammad H., van Nimwegen M., Kool M., Willart M.A., Muskens F., Hoogsteden H.C., Luttmann W., Ferrari D., Di Virgilio F., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007, 13:913-919.
58. Kurashima Y., Amiya T., Nochi T., Fujisawa K., Haraguchi T., Iba H., Tsutsui H., Sato S., Nakajima S., Iijima H., et al. Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat Commun 2012, 3:1034.
59. Kurashima Y., Amiya T., Fujisawa K., Shibata N., Suzuki Y., Kogure Y., Hashimoto E., Otsuka A., Kabashima K., Sato S., et al. The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis. Immunity 2014, 40:530-541.
60. Dagvadorj J., Shimada K., Chen S., Jones H.D., Tumurkhuu G., Zhang W., Wawrowsky K.A., Crother T.R., Arditi M. Lipopolysaccharide induces alveolar macrophage necrosis via CD14 and the P2X7 receptor leading to interleukin-1alpha release. Immunity 2015, 42:640-653.
61. Chen Y., Corriden R., Inoue Y., Yip L., Hashiguchi N., Zinkernagel A., Nizet V., Insel P.A., Junger W.G. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006, 314:1792-1795.
62. Hasko G., Csoka B., Nemeth Z.H., Vizi E.S., Pacher P. A(2B) adenosine receptors in immunity and inflammation. Trends Immunol 2009, 30:263-270.
63. Chadet S., Ivanes F., Benoist L., Salmon-Gandonniere C., Guibon R., Velge-Roussel F., Babuty D., Baron C., Roger S., Angoulvant D. Hypoxia/reoxygenation inhibits P2Y11 receptor expression and its immunosuppressive activity in human dendritic cells. J Immunol 2015, 195:651-660.
64. Bao Y., Ledderose C., Seier T., Graf A.F., Brix B., Chong E., Junger W.G. Mitochondria regulate neutrophil activation by generating ATP for autocrine purinergic signaling. J Biol Chem 2014, 289:26794-26803.
65. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta 2008, 1783:673-694.
66. Tsai S.H., Kinoshita M., Kusu T., Kayama H., Okumura R., Ikeda K., Shimada Y., Takeda A., Yoshikawa S., Obata-Ninomiya K., et al. The ectoenzyme E-NPP3 negatively regulates ATP-dependent chronic allergic responses by basophils and mast cells. Immunity 2015, 42:279-293.
67. Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., Armstrong A.J., Penuela S., Laird D.W., Salvesen G.S., et al. Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 2010, 467:863-867.
68. Yamaguchi H., Maruyama T., Urade Y., Nagata S. Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells. Elife 2014, 3:e02172.
69. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., Park D., Woodson R.I., Ostankovich M., Sharma P., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286.
70. Synnestvedt K., Furuta G.T., Comerford K.M., Louis N., Karhausen J., Eltzschig H.K., Hansen K.R., Thompson L.F., Colgan S.P. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002, 110:993-1002.
71. Li X., Zhou T., Zhi X., Zhao F., Yin L., Zhou P. Effect of hypoxia/reoxygenation on CD73 (ecto-5'-nucleotidase) in mouse microvessel endothelial cell lines. Microvasc Res 2006, 72:48-53.
72. Kumar V., Sharma A. Adenosine: an endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol 2009, 616:7-15.
73. Ohta A., Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001, 414:916-920.
74. Li L., Huang L., Ye H., Song S.P., Bajwa A., Lee S.J., Moser E.K., Jaworska K., Kinsey G.R., Day Y.J., et al. Dendritic cells tolerized with adenosine A(2)AR agonist attenuate acute kidney injury. J Clin Invest 2012, 122:3931-3942.
75. Bles N., Di Pietrantonio L., Boeynaems J.M., Communi D. ATP confers tumorigenic properties to dendritic cells by inducing amphiregulin secretion. Blood 2010, 116:3219-3226.
76. Hasko G., Cronstein B. Regulation of inflammation by adenosine. Front Immunol 2013, 4:85.
77. Crean D., Cummins E.P., Bahar B., Mohan H., McMorrow J.P., Murphy E.P. Adenosine modulates NR4A orphan nuclear receptors to attenuate hyperinflammatory responses in monocytic cells. J Immunol 2015, 195:1436-1440.
78. Ouyang X., Ghani A., Malik A., Wilder T., Colegio O.R., Flavell R.A., Cronstein B.N., Mehal W.Z. Adenosine is required for sustained inflammasome activation via the A(2)A receptor and the HIF-1alpha pathway. Nat Commun 2013, 4:2909.
79. Bajgar A., Kucerova K., Jonatova L., Tomcala A., Schneedorferova I., Okrouhlik J., Dolezal T. Extracellular adenosine mediates a systemic metabolic switch during immune response. PLoS Biol 2015, 13:e1002135.
80. Abdelmegeed M.A., Moon K.H., Hardwick J.P., Gonzalez F.J., Song B.J. Role of peroxisome proliferator-activated receptor-alpha in fasting-mediated oxidative stress. Free Radic Biol Med 2009, 47:767-778.
81. Chakravarthy M.V., Pan Z., Zhu Y., Tordjman K., Schneider J.G., Coleman T., Turk J., Semenkovich C.F. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab 2005, 1:309-322.
82. Wray J.A., Sugden M.C., Zeldin D.C., Greenwood G.K., Samsuddin S., Miller-Degraff L., Bradbury J.A., Holness M.J., Warner T.D., Bishop-Bailey D. The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo. PLoS One 2009, 4:7421e.
83. Rommelaere S., Millet V., Gensollen T., Bourges C., Eeckhoute J., Hennuyer N., Bauge E., Chasson L., Cacciatore I., Staels B., et al. PPARalpha regulates the production of serum Vanin-1 by liver. FEBS Lett 2013, 587:3742-3748.
84. Rakhshandehroo M., Hooiveld G., Muller M., Kersten S. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One 2009, 4:6796e.
85. Moffit J.S., Koza-Taylor P.H., Holland R.D., Thibodeau M.S., Beger R.D., Lawton M.P., Manautou J.E. Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate. Toxicol Appl Pharmacol 2007, 222:169-179.
86. Pitari G., Malergue F., Martin F., Philippe J.M., Massucci M.T., Chabret C., Maras B., Dupre S., Naquet P., Galland F. Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett 2000, 483:149-154.
87. Granjeaud S., Naquet P., Galland F. An ESTs description of the new Vanin gene family conserved from fly to human. Immunogenetics 1999, 49:964-972.
88. Dupre S., Cavallini D. Purification and properties of pantetheinase from horse kidney. Methods Enzymol 1979, 62:262-267.
89. Rock C.O., Calder R.B., Karim M.A., Jackowski S. Pantothenate kinase regulation of the intracellular concentration of coenzyme A. J Biol Chem 2000, 275:1377-1383.
90. Dansie L.E., Reeves S., Miller K., Zano S.P., Frank M., Pate C., Wang J., Jackowski S. Physiological roles of the pantothenate kinases. Biochem Soc Trans 2014, 42:1033-1036.
91. Nutt L.K., Buchakjian M.R., Gan E., Darbandi R., Yoon S.Y., Wu J.Q., Miyamoto Y.J., Gibbons J.A., Andersen J.L., Freel C.D., et al. Metabolic control of oocyte apoptosis mediated by 14-3-3zeta-regulated dephosphorylation of caspase-2. Dev Cell 2009, 16:856-866.
92. Comerford S.A., Huang Z., Du X., Wang Y., Cai L., Witkiewicz A.K., Walters H., Tantawy M.N., Fu A., Manning H.C., et al. Acetate dependence of tumors. Cell 2014, 159:1591-1602.
93. Pietrocola F., Galluzzi L., Bravo-San Pedro J.M., Madeo F., Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab 2015, 21:805-821.
94. Cai L., Sutter B.M., Li B., Tu B.P. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol Cell 2011, 42:426-437.
95. Leonardi R., Zhang Y.M., Rock C.O., Jackowski S. Coenzyme A: back in action. Prog Lipid Res 2005, 44:125-153.
96. Leonardi R., Rehg J.E., Rock C.O., Jackowski S. Pantothenate kinase 1 is required to support the metabolic transition from the fed to the fasted state. PLoS One 2010, 5:e11107.
97. Leone T.C., Weinheimer C.J., Kelly D.P. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 1999, 96:7473-7478.
98. van Diepen J.A., Jansen P.A., Ballak D.B., Hijmans A., Hooiveld G.J., Rommelaere S., Galland F., Naquet P., Rutjes F.P., Mensink R.P., et al. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism. J Hepatol 2014, 61:366-372.
99. Chen S., Zhang W., Tang C., Tang X., Liu L., Liu C. Vanin-1 is a key activator for hepatic gluconeogenesis. Diabetes 2014, 63:2073-2085.
100. Cortassa S., O'Rourke B., Aon M.A. Redox-optimized ROS balance and the relationship between mitochondrial respiration and ROS. Biochim Biophys Acta 2014, 1837:287-295.
101. Wang C., Cui Y., Li C., Zhang Y., Xu S., Li X., Li H., Zhang X. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet. Lipids Health Dis 2013, 12:165.
102. Okada K., Warabi E., Sugimoto H., Horie M., Gotoh N., Tokushige K., Hashimoto E., Utsunomiya H., Takahashi H., Ishii T., et al. Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet. J Gastroenterol 2013, 48:620-632.
103. Meakin P.J., Chowdhry S., Sharma R.S., Ashford F.B., Walsh S.V., McCrimmon R.J., Dinkova-Kostova A.T., Dillon J.F., Hayes J.D., Ashford M.L. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol Cell Biol 2014, 34:3305-3320.
104. Hayes J.D., Dinkova-Kostova A.T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci 2014, 39:199-218.
105. Berruyer C., Martin F.M., Castellano R., Macone A., Malergue F., Garrido-Urbani S., Millet V., Imbert J., Dupre S., Pitari G., et al. Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol 2004, 24:7214-7224.
106. Povero D., Eguchi A., Niesman I.R., Andronikou N., de Mollerat du Jeu X., Mulya A., Berk M., Lazic M., Thapaliya S., Parola M., et al. Lipid-induced toxicity stimulates hepatocytes to release angiogenic microparticles that require vanin-1 for uptake by endothelial cells. Sci Signal 2013, 6:ra88.
107. Martin F., Penet M.F., Malergue F., Lepidi H., Dessein A., Galland F., de Reggi M., Naquet P., Gharib B. Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores. J Clin Invest 2004, 113:591-597.
108. Berruyer C., Pouyet L., Millet V., Martin F.M., LeGoffic A., Canonici A., Garcia S., Bagnis C., Naquet P., Galland F. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. J Exp Med 2006, 203:2817-2827.
109. Dammanahalli K.J., Stevens S., Terkeltaub R. Vanin-1 pantetheinase drives smooth muscle cell activation in post-arterial injury neointimal hyperplasia. PLoS One 2012, 7:39106e.
110. Yoshitake H., Takeda Y., Nitto T., Sendo F. Cross-linking of GPI-80, a possible regulatory molecule of cell adhesion, induces up-regulation of CD11b/CD18 expression on neutrophil surfaces and shedding of L-selectin. J Leukoc Biol 2002, 71:205-211.
111. Nitto T., Onodera K. The linkage between coenzyme a metabolism and inflammation: roles of pantetheinase. J Pharmacol Sci 2013, 123:1-8.
112. Meghari S., Berruyer C., Lepidi H., Galland F., Naquet P., Mege J.L. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection. Eur J Immunol 2007, 37:24-32.
113. Rommelaere S., Millet V., Rihet P., Atwell S., Helfer E., Chasson L., Beaumont C., Chimini G., Sambo M.D., Viallat A., et al. Serum pantetheinase/vanin levels regulate erythrocyte homeostasis and severity of malaria. Am J Pathol 2015, 185:3039-3052.
114. Min-Oo G., Fortin A., Pitari G., Tam M., Stevenson M.M., Gros P. Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J Exp Med 2007, 204:511-524.
115. Calkins M.J., Townsend J.A., Johnson D.A., Johnson J.A. Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription. Exp Neurol 2010, 224:307-317.
116. Naquet P., Pitari G., Dupre S., Galland F. Role of the Vnn1 pantetheinase in tissue tolerance to stress. Biochem Soc Trans 2014, 42:1094-1100.
117. Kanfi Y., Naiman S., Amir G., Peshti V., Zinman G., Nahum L., Bar-Joseph Z., Cohen H.Y. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012, 483:218-221.
118. Chovatiya R., Medzhitov R. Stress, inflammation, and defense of homeostasis. Mol Cell 2014, 54:281-288.
119. Kotas M.E., Medzhitov R. Homeostasis, inflammation, and disease susceptibility. Cell 2015, 160:816-827.